প্রস্টেট ক্যান্সার
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
কোথায় যেতে হবে
এই ট্রায়ালের জন্য ভারতের ৮টি হাসপাতাল রোগীদের নিচ্ছে।
রেজিস্ট্রির সারসংক্ষেপ (টেকনিক্যাল)
Researchers are looking for a better way to treat men who have non-metastatic castration-resistant prostate cancer (nmCRPC). This is a type of cancer of the prostate that has not yet spread to other parts of the body and that keeps progressing even when the amount of male sex hormones like testosterone (also called androgens) is reduced to very low levels. To reduce androgen levels in prostate cancer patients, androgen deprivation therapy (ADT) is often used. As androgens stimulate the growth of prostate cancer cells, low levels are needed to reduce or slow the growth of these tumors. In men …
Sponsor: Bayer
NCT05348876 on ClinicalTrials.gov
Last updated on the registry 6 Jul 2026 · read by us 20 Oct 2026